Glomeria Therapeutics
Develops and commercialises medical devices to treat nephropathy.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
€2.8m | Grant | ||
| Total Funding | 000k | ||
| EUR | 2015 | 2016 | 2017 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| % growth | - | 3031 % | 71 % |
| EBITDA | 0000 | 0000 | 0000 |
| % EBITDA margin | (170959 %) | (10016 %) | 335 % |
| Profit | 0000 | 0000 | 0000 |
| % profit margin | (193934 %) | (40242 %) | (387 %) |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads